- Today, IBM announced its data-driven tool, IBM Study Advance that optimizes clinical trial protocol design by providing access to real-world patient population data, a collaborative workplace and standardizing protocol template guidance.
- IBM Study Advance’s collaborative workspace is designed to allow near real-time collaboration with study design team members who can manage and assign the team to specific sections of the protocol.
IBM Watson
Health today unveiled its newest
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
LexaGene Launches Genetic Analyzer for Detection of Pathogens like Coronavirus
- LexaGene has created a genetic analyzer that can identify specific bacteria and viruses as well as any antibiotic/antimicrobial resistance that they have, within just one hour.
- The device does this completely automatically, without the need for trained lab technicians, by amplifying the genetic material in the sample to identify it, rather than waiting for a culture which can take several days.
LexaGene Holdings, Inc., a biotechnology company that develops genetic analyzers
Read More
Verana Health Acquires PYAA Analytics; Raises $100M to Expand Real World Data Insights
- Verana Health, a health tech company (in the real-world evidence and clinical trials space) is announcing a $100M funding round today — led by GV (with participation by Bain, Define, Brook Byers and others).
- Additionally, they acquired Knoxville-based PYAA analytics, a company spun out of Oak Ridge National Laboratory to leverage the PYAA team’s capabilities to integrate imaging, genomic, and claims data sources into the existing data platform and link these data with the EHR data
Read More
Notable Launches Observational Clinical Trial for Patients with Blood Cancer
- Notable launches The ANSWer Study, it's new observational clinical trial for patients with blood cancer and is currently enrolling patients.- The primary assessment is to establish a tumor registry with annotated clinical outcomes.Notable, a San Francisco, CA-based company redefining cancer treatment with a clinically validated platform that rapidly advances drug development, is currently enrolling patients in its new observational clinical trial. The clinical trial will take place at
Read More
CVS: 4 Approaches to Reduce The Cost Impact of Gene Therapies
- While the life-changing and life-saving potential of gene therapies is tremendously exciting, finding ways to pay for these treatments is a significant challenge for families and payors.- With prices for a single treatment as high as $2 million, many employers are struggling to find ways to offer coverage without bankrupting their health plans, or even their companies.- Newly released CVS Health white paper outlines four key approaches that health plans and employers can utilize to reduce the
Read More
Duke, Deerfield Management Form Four Points Innovation to Invest Up $130M in Drug Discovery
- Duke University and Deerfield Management Company form major translation research collaboration company, Four Points Innovation. - Deerfield will invest up to $130 million of initial funding to accelerate drug discovery at Duke for 10 years. Duke University and Deerfield Management Company, a healthcare investment firm has announced the creation of a major translational research collaboration company, Four Points Innovation. Spearheaded by Duke University’s Office of Licensing &
Read More
Alphabet’s Verily, Emory Healthcare Partner to Leverage Big Data to Optimize Medication & Lab Ordering Patterns
- Alphabet’s Verily is partnering with Atlanta, GA-based Emory Healthcare on deep analysis of medications and lab ordering patterns for improved diagnosis and treatment at the point of care. - Verily is a subsidiary of Alphabet focused on life sciences and healthcare that develops tools and devices to collect, organize and activate health data, and creates interventions to prevent and manage diseaseVerily, an Alphabet company is partnering with Emory Healthcare to deploy new solutions to help
Read More
Verantos Awarded NIH Grant to Fund Clinical Phenotyping in Real-World Evidence
- Verantos has been awarded a grant from the National Institutes of Health (NIH) to fund advanced clinical phenotyping in real-world evidence (RWE) studies.- Grant number R44TR002437 ties directly to the 21st Century Cures Act's national goals of increasing the use of RWE to refine the standard of care and create a more tailored approach to therapy.Verantos, a Palo Alto, CA-based provider of regulatory-grade real-world evidence (RWE) studies, today announced that it has received a grant from the
Read More
Cleveland Clinic Awarded $12M to Study Link Between Gut Microbes & Heart Disease
- Stanley Hazen, M.D., Ph.D., director of Cleveland Clinic's Center for Microbiome & Human Health and his team has been awarded a $12M NIH grant to study the link between gut microbes, heart disease.
- The new research program will consist of three specialized projects and four supporting cores focused on the gut microbiome.
TheNational Institutes of Health (NIH) has awarded more than $12 million to Cleveland Clinic researchers to study the critical link between gut microbial pathways and
Read More
Industry 4.0 in Life Sciences: A “5C” Point of View
McKinsey & Company describes Industry 4.0 as the next phase in the digitization of the manufacturing sector that is being driven by four disruptions: the astonishing rise in data volumes, computational power and connectivity, especially new low-power wide-area networks; the emergence of analytics and business intelligence capabilities; the new forms of human-machine interaction, such as touch interfaces and augmented reality systems; and the improvements in transferring digital instructions
Read More
